GS LHF 75 mg (Tafinlar 75 mg)
Generic Name: dabrafenib
Pill imprint GS LHF 75 mg has been identified as Tafinlar 75 mg.
Tafinlar is used in the treatment of melanoma, metastatic and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tafinlar 75 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
More about Tafinlar (dabrafenib)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.